Long‐term follow‐up of diabetic and non‐diabetic patients with chronic hepatitis C successfully treated with direct‐acting antiviral agents

2020 ◽  
Author(s):  
Alessia Ciancio ◽  
Davide G. Ribaldone ◽  
Anna Dotta ◽  
Chiara Giordanino ◽  
Marco Sacco ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Antiviral Agents ◽  
Diabetic Patients ◽  
Direct Acting Antiviral ◽  
Long Term Follow Up ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents

scholarly journals The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm

2020 ◽  
Vol 9 (2) ◽  
pp. 563 ◽  
Author(s):  
Davide Giuseppe Ribaldone ◽  
Marco Sacco ◽  
Giorgio Maria Saracco
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Hepatitis C ◽  
Antiviral Agents ◽  
Clinical Impact ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents

The causal link between chronic hepatitis C and glycometabolic alterations has been confirmed by much biochemical, clinical, and epidemiological research work, but what is still controversial is the long-term clinical impact of sustained virologic response (SVR) achieved by direct-acting antiviral agents (DAAs) on patients with type 2 diabetes mellitus (DM). The aim of this paper is to summarize the biochemical and clinical consequences to DM of DAA-based therapy for hepatitis C virus (HCV) infection. An electronic search of Embase, PubMed, MEDLINE, Ovid, and the Cochrane Database of Systematic Reviews was conducted for publications assessing whether clearance of HCV achieved by interferon (IFN)-free antiviral therapy determines significant changes in glycometabolic control and clinical outcomes of diabetic patients. A beneficial effect of SVR obtained by DAA therapy on DM prevention and the short-term outcome of glycometabolic alterations are acknowledged by most of the studies. Whether this effect is maintained over the long term with a significant clinical impact on diabetic and liver disease is still a matter of debate.

Sign in / Sign up

Export Citation Format

Share Document